Pulmonary valve incompetence
Drugs: FINTEPLA
- Safetyreportversion
- 1
- Safetyreportid
- 26940057
- Primarysourcecountry
- US
- Occurcountry
- US
- Transmissiondateformat
- 102
- Transmissiondate
- 20260709
- Reporttype
- 2
- Serious
- 1
- Seriousnessdeath
- 2
- Seriousnesslifethreatening
- 2
- Seriousnesshospitalization
- 2
- Seriousnessdisabling
- 2
- Seriousnesscongenitalanomali
- 2
- Seriousnessother
- 1
- Receivedateformat
- 102
- Receivedate
- 20260630
- Receiptdateformat
- 102
- Receiptdate
- 20260630
- Fulfillexpeditecriteria
- 1
- Companynumb
- US-UCBSA-1026489
- Primarysource
- Reportercountry
- US
- Qualification
- 1
- Sender
- Sendertype
- 6
- Senderorganization
- UCB
- Receiver
- Receivertype
- 6
- Receiverorganization
- FDA
- Patient
- Patientonsetage
- 23
- Patientonsetageunit
- 801
- Patientweight
- 29
- Patientsex
- 1
- Reaction
- Reactionmeddraversionpt
- 29.0
- Reactionmeddrapt
- Pulmonary valve incompetence
- Reactionoutcome
- 6
- Drug
- Drugcharacterization
- 1
- Medicinalproduct
- FINTEPLA
- Drugauthorizationnumb
- 212102
- Drugseparatedosagenumb
- 1
- Drugdosagetext
- 4.8 MILLIGRAM PER DAY
- Drugdosageform
- Oral solution
- Drugindication
- Product used for unknown indication
- Actiondrug
- 5
- Drugadditional
- 3
- Activesubstance
- Activesubstancename
- FENFLURAMINE
- Harmonized identifiers (openFDA)
- Application number
- NDA212102
- Brand name
- FINTEPLA
- Generic name
- FENFLURAMINE
- Manufacturer name
- UCB, Inc.
- Product NDC
- 43376-322
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- FENFLURAMINE
- RxCUI
- 2381138, 2381144
- SPL ID
- 42264a61-0fc3-3a99-e063-6294a90a9595
- SPL set ID
- e88f360e-33ad-4cd6-b2de-5ef885857c5d
- Package NDC
- 43376-322-30, 43376-322-36
- UNII
- 2DS058H2CF
- Summary
- Narrativeincludeclinical
- CASE EVENT DATE: 20260531
